Present On Admission Exempt Codes
ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2027 CMS POA exempt list.
Advertisements
Codes on this list
38,399 codes, page 274 of 384.
- T46.1X2DPoisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
- T46.1X2SPoisoning by calcium-channel blockers, intentional self-harm, sequela
- T46.1X3DPoisoning by calcium-channel blockers, assault, subsequent encounter
- T46.1X3SPoisoning by calcium-channel blockers, assault, sequela
- T46.1X4DPoisoning by calcium-channel blockers, undetermined, subsequent encounter
- T46.1X4SPoisoning by calcium-channel blockers, undetermined, sequela
- T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
- T46.1X5SAdverse effect of calcium-channel blockers, sequela
- T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounter
- T46.1X6SUnderdosing of calcium-channel blockers, sequela
- T46.2X1DPoisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
- T46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
- T46.2X2DPoisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
- T46.2X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequela
- T46.2X3DPoisoning by other antidysrhythmic drugs, assault, subsequent encounter
- T46.2X3SPoisoning by other antidysrhythmic drugs, assault, sequela
- T46.2X4DPoisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
- T46.2X4SPoisoning by other antidysrhythmic drugs, undetermined, sequela
- T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
- T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
- T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounter
- T46.2X6SUnderdosing of other antidysrhythmic drugs, sequela
- T46.3X1DPoisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
- T46.3X1SPoisoning by coronary vasodilators, accidental (unintentional), sequela
- T46.3X2DPoisoning by coronary vasodilators, intentional self-harm, subsequent encounter
- T46.3X2SPoisoning by coronary vasodilators, intentional self-harm, sequela
- T46.3X3DPoisoning by coronary vasodilators, assault, subsequent encounter
- T46.3X3SPoisoning by coronary vasodilators, assault, sequela
- T46.3X4DPoisoning by coronary vasodilators, undetermined, subsequent encounter
- T46.3X4SPoisoning by coronary vasodilators, undetermined, sequela
- T46.3X5DAdverse effect of coronary vasodilators, subsequent encounter
- T46.3X5SAdverse effect of coronary vasodilators, sequela
- T46.3X6DUnderdosing of coronary vasodilators, subsequent encounter
- T46.3X6SUnderdosing of coronary vasodilators, sequela
- T46.4X1DPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
- T46.4X1SPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
- T46.4X2DPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
- T46.4X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
- T46.4X3DPoisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
- T46.4X3SPoisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
- T46.4X4DPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
- T46.4X4SPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
- T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
- T46.4X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequela
- T46.5X1DPoisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
- T46.5X1SPoisoning by other antihypertensive drugs, accidental (unintentional), sequela
- T46.5X2DPoisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
- T46.5X2SPoisoning by other antihypertensive drugs, intentional self-harm, sequela
- T46.5X3DPoisoning by other antihypertensive drugs, assault, subsequent encounter
- T46.5X3SPoisoning by other antihypertensive drugs, assault, sequela
- T46.5X4DPoisoning by other antihypertensive drugs, undetermined, subsequent encounter
- T46.5X4SPoisoning by other antihypertensive drugs, undetermined, sequela
- T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounter
- T46.5X5SAdverse effect of other antihypertensive drugs, sequela
- T46.5X6DUnderdosing of other antihypertensive drugs, subsequent encounter
- T46.5X6SUnderdosing of other antihypertensive drugs, sequela
- T46.6X1DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
- T46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
- T46.6X2DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
- T46.6X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
- T46.6X3DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
- T46.6X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
- T46.6X4DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
- T46.6X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
- T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.7X1DPoisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
- T46.7X1SPoisoning by peripheral vasodilators, accidental (unintentional), sequela
- T46.7X2DPoisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
- T46.7X2SPoisoning by peripheral vasodilators, intentional self-harm, sequela
- T46.7X3DPoisoning by peripheral vasodilators, assault, subsequent encounter
- T46.7X3SPoisoning by peripheral vasodilators, assault, sequela
- T46.7X4DPoisoning by peripheral vasodilators, undetermined, subsequent encounter
- T46.7X4SPoisoning by peripheral vasodilators, undetermined, sequela
- T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounter
- T46.7X5SAdverse effect of peripheral vasodilators, sequela
- T46.7X6DUnderdosing of peripheral vasodilators, subsequent encounter
- T46.7X6SUnderdosing of peripheral vasodilators, sequela
- T46.8X1DPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
- T46.8X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
- T46.8X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
- T46.8X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
- T46.8X3DPoisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
- T46.8X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequela
- T46.8X4DPoisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
- T46.8X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
- T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
- T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequela
- T46.901DPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
- T46.901SPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
- T46.902DPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
- T46.902SPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
- T46.903DPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
- T46.903SPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela